Shifting risk-stratified early prostate cancer detection to a primary healthcare setting.
Renée HogenhoutDaniël F OssesArnout R AlbertsHanne G Buizer-RijksenSebastiaan RemmersMonique J RoobolPublished in: BJU international (2022)
Multivariable risk-stratification for PCa detection using the RPCRC in a primary healthcare diagnostic facility could reduce 68% of referrals to secondary healthcare relative to the PSA threshold of 3.0 ng/mL with a high csPCa detection rate in those men biopsied. This strategy can be considered safe according to the observational data that showed low proportions of csPCa among men considered low-risk.